Cryomass Technologies Stock Shares Outstanding
| CRYM Stock | USD 0.02 0.0001 0.62% |
Cryomass Technologies fundamentals help investors to digest information that contributes to Cryomass Technologies' financial success or failures. It also enables traders to predict the movement of Cryomass OTC Stock. The fundamental analysis module provides a way to measure Cryomass Technologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cryomass Technologies otc stock.
Cryomass |
Cryomass Technologies OTC Stock Shares Outstanding Analysis
Cryomass Technologies' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Cryomass Technologies Shares Outstanding | 202.53 M |
Most of Cryomass Technologies' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cryomass Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Cryomass Technologies has 202.53 M of shares currently outstending. This is 12.18% higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The shares outstanding for all United States stocks is 64.58% higher than that of the company.
Cryomass Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cryomass Technologies' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Cryomass Technologies could also be used in its relative valuation, which is a method of valuing Cryomass Technologies by comparing valuation metrics of similar companies.Cryomass Technologies is currently under evaluation in shares outstanding category among its peers.
Cryomass Fundamentals
| Return On Equity | -1.16 | |||
| Return On Asset | -0.33 | |||
| Current Valuation | 42.41 M | |||
| Shares Outstanding | 202.53 M | |||
| Shares Owned By Insiders | 25.92 % | |||
| Price To Book | 4.44 X | |||
| Gross Profit | 37.18 K | |||
| EBITDA | (7.9 M) | |||
| Net Income | (12.86 M) | |||
| Cash And Equivalents | 2.19 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 177.08 K | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 2.07 X | |||
| Book Value Per Share | 0.05 X | |||
| Cash Flow From Operations | (5.6 M) | |||
| Earnings Per Share | (0.08) X | |||
| Beta | 5.22 | |||
| Market Capitalization | 35.44 M | |||
| Total Asset | 15.58 M | |||
| Net Asset | 15.58 M |
About Cryomass Technologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cryomass Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cryomass Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cryomass Technologies based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Cryomass OTC Stock
Cryomass Technologies financial ratios help investors to determine whether Cryomass OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cryomass with respect to the benefits of owning Cryomass Technologies security.